Felodipine in the treatment of severe refractory hypertension

Journal of Human Hypertension

Volumn 10, Issue SUPPL. 3, 1996, Pages

  Nussinovitch, Naomi ^a   Carroll, J ^b   Shamiss, A ^b   Grossman, E ^b   Katz, A ^b   Rachima, C ^b   Rosenthal, T ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Felodipine; Refractory hypertension

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; FELODIPINE; GLUCOSE; NIFEDIPINE; VASODILATOR AGENT;

ADULT; AGED; BLOOD PRESSURE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG POTENCY; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HOT FLUSH; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PULSE RATE;

ADOLESCENT; ADULT; AGED; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIASTOLE; FELODIPINE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SYSTOLE;

EID: 0029761596     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Ljung B. Vascular selectivity of felodipine. Drugs 1985; 29 (Suppl 2): 46-58.
2. Fagard R et al. Acute haemodynamic and humoral responses to felodipine and metoprolol in mild hypertension. Eur J Pharmacol 1987; 32: 71-75.
3. Carruthers SG, Vint-Reed C. Antihypertensive effect and tolerability of felodipine extended release (ER) in comparison with felodipine plain tablets (FT) and placebo in hypertensives on a diuretic. Canadian Study Group Clin Inves Med 1993; 16: 386-394.
4. Cooperative Study Group. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Drugs 1987; 34 (Suppl 3): 139-148.
5. Abelardo NS et al. A comparison of felodipine and nifedipine as monotherapies for the treatment of mild to moderate hypertension. J Hum Hypertens 1989; 3: 57-59.
6. Muir AL, Wathen CG. The use of felodipine in the treatment of severe hypertension. Drugs 1987; 34 (Suppl 3): 120-123.
7. Andersson OK, Granerus G, Volkmann R, Wysocki M. Hemodynamic and long-term renal effects of felodipine in severely hypertensive patients. J Cardiovas Pharm 1990; 15: (Suppl 4): S41.
8. Herlitz H, et al. Clinical evaluation of felodipine in patients with refractory hypertension. Drugs 1987; 34: (Suppl 3): 151-155.
9. Todd PA, Faulds D. Felodipine, a review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders. Drugs 1992; 44 (2): 251-277.
10. Aberg H, Lindsjo M, Morlin B, Comparative trial of felodipine and nifedipine in refractory hypertension. Drugs 1985; 29 (Suppl 2): 117-123.
11. Andersson OK, Hender T, Granerus G. Felodipine in combination with a beta-blocker and a diuretic in chronic treatment of patients with refractory primary hypertension. Drugs 1987; 34 (Suppl 3): 156-160.
12. Morgan TO. A review of the antihypertensive effects of felodipine alone or in combination. J Cardiovas Pharm 1990; 15 (Suppl 4): S76-S84.
13. Trenkwalder P, Elmfeldt D. Improving the therapeutic balance between efficacy and tolerability in antihypertensive drugs - the rational and benefits of combining felodipine and metoprolol J Hum Hypertens 1995; 9 (Suppl 2): S37-S42.
14. Hender T (on behalf of the Swedish Multicenter Study Group). Clinical evaluation of felodipine in hypertensive patients previously treated with a triple drug regimen. Drugs 1987; 34 (Suppl 3): 161.
15. Hansson L et al. Antihypertensive effect of felodipine or hydralazine when added to beta-blocker therapy. J Cardiovas Pharmacol 1988; 12: 94-101.
16. Jackson B, Morgan TO, Gibson J, Anderson A. Felodipine vs prazosin as an addition to a beta-blocker in the treatment of essential hypertension: the Australian Multicentre Study. Drugs 1987; 34 (Suppl 3): 109-119.
17. Wathen CG, MacLeod D, Tucker L, Muir AL. Felodipine as a replacement for minoxidil in the treatment of severe hypertension. Eur Heart J 1986; 7: 893-897.
18. Bursztyn M, Many A, Rosenthal T. Nifedipine in the treatment of hypertension in systemic lupus erythematosus. Angiology 1987; 38: 359-362.
19. Lorimer AR, Pringle SD. The safety of felodipine. J Cardiovas Pharmacol 1990; 15 (Suppl 4): S85-S89.
20. Gradman AH. Treatment of hypertension with felodipine in patients with concomitant diseases. Clin Card 1993; 16: 294-301.
21. Zanchetti A, Leonetti G. Natriuretic effects of calcium antagonists. Clinical implications. Drugs 1990; 40: (Suppl 2): 15-21.
22. Capewell S et al. Felodipine in type II diabetes mellitus. J Cardiovas Pharm 1990; 15 (Suppl 4): S111-S114.
23. Shionoiri H et al. Felodipine therapy may not alter glucose and lipid metabolism in hypertensives. Felodipine Multicenter Prospective Study Group in Japan. Hypertension 1994; 23 (Suppl 1): 1215-1219.
24. Cerasola G et al. Reversal of cardiac hypertrophy and left ventricular function with the calcium antagonist felodipine in hypertensive patients. J Hum Hypertens 1990; 4: 703-708.
25. Myers MG, Leenen FH, Tanner J. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass. Am J Hypertens 1995; 8: (7): 712-718.
26. Saltiel E, Ellrodt AG, Monk JP, Langley MS. Felodipine - a review of its pharmacodynamic and pharmacokinetic properties and the therapeutic use in hypertension. Drugs 1988; 36: 387-428.
27. Larsson R et al. Felodipine in the treatment of patients with severe hypertension and impaired renal function. Cardiovasc Drugs Ther 1990; 4(1): 253-259.
28. Herlitz H, Granerus G, Aurell M. Long-term effects of felodipine on blood pressure and renal hemodynamics in severe hypertension. J Cardiovas Pharm 1990; 15 (Suppl 4): S100-S102.
29. Lok H (on behalf of the GP Multicenter Study Group). Felodipine in elderly hypertensives. J Hum Hypertens 1989; 3: 467-470.
30. Hosie J, Mulder AW, Westberg B. Felodipine once daily in elderly hypertensives. Binational MC Study Group (UK and The Netherlands). J Hum Hypertens 1991; 5 (1): 49-53.
31. DeQuattro V. Efficacy and safety of felodipine, a new dihydropyridine calcium channel blocker in elderly hypertensive patients. Clin Exp Hypertens A 1992; 14 (6): 965-987.